226 related articles for article (PubMed ID: 27830574)
1. Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.
Haroon E; Miller AH
Curr Top Behav Neurosci; 2017; 31():173-198. PubMed ID: 27830574
[TBL] [Abstract][Full Text] [Related]
2. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.
Haroon E; Fleischer CC; Felger JC; Chen X; Woolwine BJ; Patel T; Hu XP; Miller AH
Mol Psychiatry; 2016 Oct; 21(10):1351-7. PubMed ID: 26754953
[TBL] [Abstract][Full Text] [Related]
3. IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.
Haroon E; Woolwine BJ; Chen X; Pace TW; Parekh S; Spivey JR; Hu XP; Miller AH
Neuropsychopharmacology; 2014 Jun; 39(7):1777-85. PubMed ID: 24481242
[TBL] [Abstract][Full Text] [Related]
4. Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.
Haroon E; Felger JC; Woolwine BJ; Chen X; Parekh S; Spivey JR; Hu XP; Miller AH
Brain Behav Immun; 2015 May; 46():17-22. PubMed ID: 25500218
[TBL] [Abstract][Full Text] [Related]
5. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia.
Haroon E; Chen X; Li Z; Patel T; Woolwine BJ; Hu XP; Felger JC; Miller AH
Transl Psychiatry; 2018 Sep; 8(1):189. PubMed ID: 30202011
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon-α on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study.
Taylor MJ; Godlewska B; Near J; Christmas D; Potokar J; Collier J; Klenerman P; Barnes E; Cowen PJ
Psychol Med; 2014 Mar; 44(4):789-95. PubMed ID: 23659574
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, glutamate, and glia in depression: a literature review.
McNally L; Bhagwagar Z; Hannestad J
CNS Spectr; 2008 Jun; 13(6):501-10. PubMed ID: 18567974
[TBL] [Abstract][Full Text] [Related]
8. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
Lally N; Nugent AC; Luckenbaugh DA; Ameli R; Roiser JP; Zarate CA
Transl Psychiatry; 2014 Oct; 4(10):e469. PubMed ID: 25313512
[TBL] [Abstract][Full Text] [Related]
9. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
[TBL] [Abstract][Full Text] [Related]
10. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
Abdallah CG; Sanacora G; Duman RS; Krystal JH
Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
[TBL] [Abstract][Full Text] [Related]
11. The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.
Felger JC
Curr Top Behav Neurosci; 2017; 31():199-219. PubMed ID: 27225499
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
[TBL] [Abstract][Full Text] [Related]
13. Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla.
Godlewska BR; Masaki C; Sharpley AL; Cowen PJ; Emir UE
Psychol Med; 2018 Jul; 48(10):1731-1737. PubMed ID: 29224573
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
Witkin JM; Mitchell SN; Wafford KA; Carter G; Gilmour G; Li J; Eastwood BJ; Overshiner C; Li X; Rorick-Kehn L; Rasmussen K; Anderson WH; Nikolayev A; Tolstikov VV; Kuo MS; Catlow JT; Li R; Smith SC; Mitch CH; Ornstein PL; Swanson S; Monn JA
J Pharmacol Exp Ther; 2017 Apr; 361(1):68-86. PubMed ID: 28138040
[TBL] [Abstract][Full Text] [Related]
15. Imaging the Role of Inflammation in Mood and Anxiety-related Disorders.
Felger JC
Curr Neuropharmacol; 2018; 16(5):533-558. PubMed ID: 29173175
[TBL] [Abstract][Full Text] [Related]
16. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
Nazlı ŞB; Sevindik M
Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
[TBL] [Abstract][Full Text] [Related]
17. Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: an 11.7 T 1H-MRS study in rats.
Perrine SA; Ghoddoussi F; Michaels MS; Sheikh IS; McKelvey G; Galloway MP
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():9-15. PubMed ID: 24246571
[TBL] [Abstract][Full Text] [Related]
18. Ketamine and other glutamate receptor modulators for depression in adults.
Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
[TBL] [Abstract][Full Text] [Related]
19. [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].
Paslakis G; Gass P; Deuschle M
Fortschr Neurol Psychiatr; 2011 Apr; 79(4):204-12. PubMed ID: 21117011
[TBL] [Abstract][Full Text] [Related]
20. Changes in metabolites in the brain of patients with fibromyalgia after treatment with an NMDA receptor antagonist.
Fayed N; Oliván B; Lopez Del Hoyo Y; Andrés E; Perez-Yus MC; Fayed A; Angel LF; Serrano-Blanco A; Roca M; Garcia Campayo J
Neuroradiol J; 2019 Dec; 32(6):408-419. PubMed ID: 31215319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
